Relationship Between Immunity and Metabolism in Patients Receiving Immune Checkpoint Inhibitors for Advanced Cancer. ( RIMEC )
Condition(s):Metabolism Disorder; Cancer; Immune Checkpoint InhibitorsLast Updated:November 19, 2021Recruiting
Hide Studies Not Open or Pending
Condition(s):Metabolism Disorder; Cancer; Immune Checkpoint InhibitorsLast Updated:November 19, 2021Recruiting
Condition(s):Non-Small-Cell Lung CancerLast Updated:June 7, 2023Withdrawn
Condition(s):Muscle Weakness; Atrophy, Muscle; Cachexia; Sarcopenia; Stem Cell Transplantation; Mesenchymal Stem CellsLast Updated:October 11, 2023Not yet recruiting
Condition(s):Non Small Cell Lung CancerLast Updated:August 21, 2019Completed
Condition(s):Liver Cancer; Lung CancerLast Updated:November 30, 2020Completed
Condition(s):Cancer; Cancer, LungLast Updated:February 28, 2024Recruiting
Condition(s):CancerLast Updated:February 1, 2021Completed
Condition(s):Non-Small Cell Lung CancerLast Updated:August 2, 2019Completed
Condition(s):NSCLCLast Updated:May 10, 2021Unknown status
Condition(s):Non-small Cell Lung CancerLast Updated:November 22, 2019Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.